East Carolina University Health is hoping to improve the lives of people living with sickle cell disease.  People with sickle cell can experience extreme pain, breathing problems, and a higher risk of infection, but through ground-breaking research, ECU researchers hope to improve individuals suffering from the disease quality of life.

“Right here at this hospital, we have currently at least ten clinical trials looking at these new drugs for sickle cell disease. The drug called Crizanlizumab, which was approved in 2019, we were the highest enrolling site, studying that drug here, if you look at all sites in the country and the world,” says Dr. Beng Fuh, Pediatric Hematology-Oncology Specialist at ECU Health. [source]

Read the full article and learn more about this life-saving research here.

Want to get involved in the fight against Sickle Cell Disease? The Neuse Pamlico Sound Women’s Coalition will host its annual 5K Walk/Run to help raise awareness and funding, March 11 in New Bern.